Salivary amyloid β42 levels in mild cognitive impairment among aged diabetics

被引：0

作者：

Doha Rasheedy

Nermien Naim Adly

Ramy Mahdy Ahmed

Moatassem Salah Amer

机构：

[1] Ain Shams University,Geriatrics and Gerontology Department, Faculty of Medicine

[2] Geriatric Medicine,undefined

[3] Ministry of Health,undefined

来源：

European Geriatric Medicine | 2019年 / 10卷

关键词：

Alzheimer’s disease markers; MCI in diabetics; Salivary Aβ42; Cognition in Type 2 diabetes mellitus;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

页码：631 / 638

页数：7

共 50 条

[41] Elevated CSF neurofilament levels are associated with risk of Mild Cognitive Impairment among individuals with and without low CSF amyloid-beta
Mielke, Michelle
Syrjanen, Jeremy
Blennow, Kaj
Zetterberg, Henrik
Skoog, Ingmar
Hagen, Clinton
Van Harten, Argonde
Knopman, David
Jack, Clifford
Petersen, Ronald
Kern, Silke
NEUROLOGY, 2018, 90
[42] Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology
Kim, Keun You
Ha, Junghee
Kim, Minae
Cho, So Yeon
Kim, Hyunjeong
Kim, Eosu
ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
[43] Communicating mild cognitive impairment diagnoses with and without amyloid imaging
Grill, Joshua D.
Apostolova, Liana G.
Bullain, Szofia
Burns, Jeffrey M.
Cox, Chelsea G.
Dick, Malcolm
Hartley, Dean
Kawas, Claudia
Kremen, Sarah
Lingler, Jennifer
Lopez, Oscar L.
Mapstone, Mark
Pierce, Aimee
Rabinovici, Gil
Roberts, J. Scott
Sajjadi, Seyed Ahmad
Teng, Edmond
Karlawish, Jason
ALZHEIMERS RESEARCH & THERAPY, 2017, 9
[44] Apathy Is Associated With Increased Amyloid Burden in Mild Cognitive Impairment
Marshall, Gad A.
Donovan, Nancy J.
Lorius, Natacha
Gidicsin, Christopher M.
Maye, Jacqueline
Pepin, Lesley C.
Becker, J. Alex
Amariglio, Rebecca E.
Rentz, Dorene M.
Sperling, Reisa A.
Johnson, Keith A.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (04) : 302 - 307
[45] Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology
Keun You Kim
Junghee Ha
Minae Kim
So Yeon Cho
Hyunjeong Kim
Eosu Kim
Alzheimer's Research & Therapy, 14
[46] Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
van Bergen, J. M. G.
Li, X.
Hua, J.
Schreiner, S. J.
Steininger, S. C.
Quevenco, F. C.
Wyss, M.
Gietl, A. F.
Treyer, V.
Leh, S. E.
Buck, F.
Nitsch, R. M.
Pruessmann, K. P.
van Zijl, P. C. M.
Hock, C.
Unschuld, P. G.
SCIENTIFIC REPORTS, 2016, 6
[47] Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment
Liu, Shan
Suzuki, Hideaki
Ito, Hitomi
Korenaga, Tatsumi
Akatsu, Hiroyasu
Meno, Kohji
Uchida, Kazuhiko
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 85 - 97
[48] Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
Maserejian, Nancy
Bian, Shijia
Wang, Wenting
Jaeger, Judith
Syrjanen, Jeremy A.
Aakre, Jeremiah
Jack, Clifford R.
Mielke, Michelle M.
Gao, Feng
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 710 - 720
[49] Down syndrome: Distribution of brain amyloid in mild cognitive impairment
Keator, David B.
Phelan, Michael J.
Taylor, Lisa
Doran, Eric
Krinsky-McHale, Sharon
Price, Julie
Ballard, Erin E.
Kreisl, William C.
Hom, Christy
Nguyen, Dana
Pulsifer, Margaret
Lai, Florence
Rosas, Diana H.
Brickman, Adam M.
Schupf, Nicole
Yassa, Michael A.
Silverman, Wayne
Lott, Ira T.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
[50] PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg, Anton
Engler, Henry
Almkvist, Ove
Blomquist, Gunnar
Hagman, Goran
Wall, Anders
Ringheim, Anna
Langstrom, Bengt
Nordberg, Agneta
NEUROBIOLOGY OF AGING, 2008, 29 (10) : 1456 - 1465

← 1 2 3 4 5 →